Reducing costs and improving outcomes of percutaneous coronary interventions

American Journal of Managed Care

Volumn 9, Issue 5, 2003, Pages 365-372

  Moscucci, Mauro ^a   Muller, David W ^a,c   Watts, Charles M ^b   Bahl, Vinita ^b   Bates, Eric R ^a   Werns, Steven W ^a   Kline Rogers, Eva ^a   Karavite, Dean ^a   Eagle, Kim A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; HEPARIN;

ACCOUNTING; ADULT; ARTICLE; ATHERECTOMY; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HEART CATHETERIZATION; HOSPITAL COST; HOSPITAL PURCHASING; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL TECHNOLOGY; MORTALITY; OUTCOMES RESEARCH; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER; REGRESSION ANALYSIS; RISK ASSESSMENT; STANDARDIZATION; SURGICAL INSTRUMENT; TRANSLUMINAL CORONARY ANGIOPLASTY; VALIDATION PROCESS;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COMPETITIVE BIDDING; CORONARY DISEASE; COST CONTROL; FEMALE; HEALTH SERVICES RESEARCH; HOSPITAL COSTS; HOSPITALS, UNIVERSITY; HUMANS; MALE; MICHIGAN; MIDDLE AGED; PROSPECTIVE STUDIES; RISK ADJUSTMENT; TREATMENT OUTCOME;

EID: 0038287895     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Ellis SG, Vandormael MG, Cowley MJ, et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel disease: Implications for patient selection. Circ J Am Heart Assoc. 1990;82:1193-1202.
2. Popma JJ, Satler LF, Pichard AD, et al. Vascular complications after balloon and new device angioplasty. Circ J Am Heart Assoc. 1993;86:1569-1578.
3. Moscucci M, Mansour KA, Kent KC, et al. Peripheral vascular complications of directional coronary atherectomy and stenting predictors, management and outcome. Am J Cardiol. 1994;74:448-453.
4. Friedman HZ, Cragg DR, Glazier SM, et al. Randomized prospective evaluation of prolonged versus abbreviated intravenous heparin therapy after coronary angioplasty. J Am Coll Cardiol. 1994;24:1214-1219.
5. Rabah M, Mason D, Muller DWM et al. Heparin after percutaneous intervention (HAPI): A prospective multicenter randomized trial of 3 heparin regimens after successful coronary intervention. J Am Coll Cardiol. 1999;34:461-467.
6. Ellis SG, Miller DP, Brown KJ, et al. In-hospital cost of percutaneous coronary revascularization. Critical determinants and implications. Circ J Am Heart Assoc. 1995;92:741-747.
7. O'Connor GT, Malenka DJ, Quinton H, et al. For the Northern New England Cardiovaslcular Disease Study Group. Multivariate prediction of in-hospital death following percutaneous coronary interventions in 1994-1996. J Am Coll Cardiol. 1999;34:681-691.
8. Moscucci M, O'Connor GT, Ellis SG, et al. Validation of risk adjustment models for in-hospital percutaneous transluminal coronary angioplasty mortality on an independent data set. J Am Coll Cardiol. 1999;34:692-697.
9. DeLong ER, Peterson ED, DeLong DM, Muhlbaier LH, Hackett S, Mark DB. Comparing, risk-adjustment methods for provider profiling. Stat Med. 1997;16:2645-2664.
10. Hlatky MA, Lipscomb J, Nelson C, et al. Resource use and cost of initial coronary revascularization. Coronary angioplasty versus coronary bypass surgery. Circ J Am Heart Assoc. 1990;82(suppl):IV-208-213.
11. Cohen DJ, Breall JA, Ho KKL, et al. Economics of elective coronary revascularization. Comparison of costs and charges for conventional angioplasty, directional atherectomy, stenting and bypass surgery. J Am Coll Cardiol. 1993;22:1052-1059.
12. Eagle KA, Moscucci M, Kline-Roberts E, et al. Evaluating and improving the delivery of heart care: The University of Michigan experience. Am J Manag Care. 1998;4:1300-1309.
13. Kline-Rogers E, Muller DWM, Werns SW, et al. The influence of critical pathways to maximize same day sheath pulling on an interventional cardiology service: Implications for length of stay and complications. J Clin Outcomes Manage. 1996;3:53-55.
14. Plante S, Strauss BH, Goulet G, Watson RK, Chisolm RJ. Re-use of balloon catheters for coronary angioplasty: A potential cost-saving strategy? J Am Coll Cardiol. 1994;24:1475-1481.
15. O'Keefe JH Jr, Gernon C, McCallister BD, Ligon RW, Hartzler GO. Safety and cost effectiveness of combined coronary angiography and angioplasty. Am Heart J. 1991;122:50-54.
16. Rozenman Y, Gilon D, Zelingher J, et al. One-stage coronary angiography and angioplasty. Am J Cardiol. 1995;75:30-33.
17. Califf RM. Restenosis: The cost to society. Am Heart J. 1995;130:680-684.
18. Cohen DJ, Breall JA, Ho KK, et al. Evaluating the potential cost effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease. Use of a decision analytic model. Circ J Am Heart Assoc. 1994;89:1859-1874.
19. Mark DB, Talley D, Topol EJ et al. Economic assessment of platelet glycoprotein IIb/IIIa inhibition for the prevention of ischemic complications of high risk coronary angioplasty. Circ J Am Heart Assoc. 1996;94:629-635.
20. Topol EJ, Leya F, Pinkerton CA et al. A comparison of directional atherectomy with coronary angioplasty in patients with coronary disease. N Engl J Med. 1993;329:221-227.
21. Cohen DJ, Becker ER, Culler SD, et al. Impact of patient characteristics, complications, and facility volume on the costs and time of cardiac catheterization and coronary angioplasty in 70 catheterization laboratories. Am J Cardiol. 2000;86:595-601.
22. Moscucci M, Ricciardi M, Kline-Rogers E, et al. Frequency, predictors and appropriateness of blood transfusion after percutaneous coronary interventions. Am J Cardiol. 1998;81:702-707.
23. McGrath PD, Malenka DJ, Wennberg DE, et al. Changing outcomes in percutaneous coronary interventions. A study of 34 752 procedures in Northern New England, 1990 to 1997; J Am Coll Cardiol. 1999;34:674-680
24. Morrison DA, Sethi G, Sacks J et al. Percutanoeus coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: A multicenter, randomized trial. J Am Coll Cardiol. 2001;38:143-149.